Kennith Swafford

Researcher

UAMS

Last publication 2025 Last refreshed 2026-05-16

faculty

3 h-index 57 pubs 25 cited

Research Areas

Links

ORCID

OverviewAI-generated summary

Kennith Swafford's research focuses on investigating molecular targets and pathways implicated in cancer, with a particular emphasis on lymphoma and oncogenic genes. His recent publications explore the role of NEK2 as a therapeutic target in lymphoma, examining its regulation of oncogenic pathways. Swafford has also investigated novel therapeutic strategies targeting specific DNA structures, such as G-quadruplexes, within the promoter regions of oncogenes like CARD11 and MYD88. These studies aim to identify new avenues for cancer treatment by understanding the functional significance of these DNA structures in regulating gene expression relevant to immune response and cancer development. Swafford has a significant publication record with over 50 papers and collaborates extensively with researchers at the University of Arkansas for Medical Sciences, including Mason McCrury, Vijay Patel, Ying-Zhi Xu, and Sydnye L. Shuttleworth.

Metrics

h-index: 3
Publications: 57
Citations: 25

Selected Publications

G-quadruplex and i-motif DNA structures form in the promoter of the key innate immune adaptor MYD88 (2025)

5 citations DOI OpenAlex
Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma (2023)

13 citations DOI OpenAlex
Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group (2022)

6 citations DOI OpenAlex